Cytokinetics (CYTK) Institutional Ownership

Of the 335 institutional investors that purchased Cytokinetics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: California State Teachers Retirement System ($10.80M), Norges Bank ($2.98M), Deep Track Capital LP ($2.52M), Woodline Partners LP ($1.52M), Vestal Point Capital LP ($1.48M), Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. ($1.25M), and Capital International Investors ($1.11M).

Institutional investors have bought a total of 25,495,684 shares in the last 24 months. This purchase volume represents approximately $1.81B in transactions.

Of the 131 institutional investors that sold Cytokinetics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Readystate Asset Management LP ($35.01M), T. Rowe Price Investment Management Inc. ($11.05M), Vestal Point Capital LP ($2.25M), Polar Capital Holdings Plc ($2.02M), Wells Fargo & Company MN ($1.91M), Alliancebernstein L.P. ($1.15M), and Melqart Asset Management UK Ltd ($703.82K).

Institutional investors have sold a total of 61,086,727 shares in the last 24 months. This volume of shares sold represents approximately $3.52B in transactions.